Related Content
June 8, 2020 – BD (Becton, Dickinson and Company) launched the Halo One Thin-Walled Guiding Sheath, designed to perform ...
June 08, 2020
August 29, 2017 — C.R. Bard Inc. announced the Lutonix 035 Drug Coated Balloon PTA Catheter (DCB) has been granted ...
August 29, 2017
DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology technologies he ...
November 18, 2016
Feature | Peripheral Artery Disease (PAD)| Dave Fornell
It is estimated that more than 10 million people in the United States are affected by peripheral arterial disease (PAD) ...
February 22, 2016
In 2015, the FDA approved the first two drug-coated balloons for the U.S. market to treat peripheral artery disease in ...
April 02, 2015
Feature | Drug-Eluting Balloons| Dave Fornell
Drug-eluting balloons (DEBs), also referred to as drug-coated balloons (DCBs), have been one of the long-awaited new ...
February 19, 2015
February 13, 2015 — Boston Scientific and C. R. Bard announced a deal where Boston Scientific will distribute the ...
February 13, 2015
January 30, 2015 — ECRI Institute has created a report that offers an overview of drug-eluting balloon (DEB) technology ...
January 30, 2015
October 13, 2014 — C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix 035 ...
October 13, 2014
Bard’s Drug Coated Balloon, Below the Knee Clinical Trial Discussed at Leipzig Interventional Course
January 30, 2014 — Experts presented six-month LEVANT 2 trial results for C. R. Bard Inc.’s Lutonix drug coated balloon ...
January 28, 2014© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now